As of 2026-10-11, the Intrinsic Value of GeneTether Therapeutics Inc (GTTX.CN) is -0.07 CAD. This GTTX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 CAD, the upside of GeneTether Therapeutics Inc is -165.59%.
Based on its market price of 0.10 CAD and our intrinsic valuation, GeneTether Therapeutics Inc (GTTX.CN) is overvalued by 165.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.07 - -0.07 | -0.07 | -165.59% |
| P/E | 0.10 - 0.10 | 0.10 | -0.3% |
| DDM - Stable | (0.02) - (0.03) | (0.03) | -127.3% |
| DDM - Multi | (0.01) - (0.02) | (0.01) | -115.0% |
| Market Cap (mil) | 7.57 |
| Beta | 5.90 |
| Outstanding shares (mil) | 75.74 |
| Enterprise Value (mil) | 6.10 |
| Market risk premium | 5.10% |
| Cost of Equity | 43.66% |
| Cost of Debt | 5.00% |
| WACC | 23.67% |